Carbon Monoxide: To Boldly Go Where NO Has Gone Before
Science's STKE · 27.04.2004 · 2004 (230)
DOI: 10.1126/stke.2302004re6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science's STKE, erschienen am 27.04.2004. Verfasst von Stefan W Ryter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, MUH 628 NW, 3459 Fif…. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The discovery that nitric oxide (NO) has powerful vasoactive properties identical to those of endothelial-derived relaxing factor spawned a vast body of research investigating the physiological actions of small gas molecules. NO, which arises endogenously through the action of nitric oxide synthase (NOS) enzymes, is a highly reactive gas that plays important roles in the regulation of vascular and immune function. Carbon monoxide (CO), a similar yet much more chemically stable gas, occurs in nature as a product of the oxidation or combustion of organic materials. CO also arises in cells and tissues as a byproduct of heme oxygenase (HO) activity, which degrades heme to biliverdin-IXα. Like NO, CO acts as a vasorelaxant and may regulate other vascular functions such as platelet aggregation and smooth muscle proliferation. CO has also been implicated as a neurotransmitter in the central nervous system. HO-1, the inducible form of HO, confers cytoprotection against oxidative stress in vitro and in vivo . CO, when applied at low concentration, exerts potent cytoprotective effects mimicking those of HO-1 induction, including down-regulation of inflammation and suppression of apoptosis. Many of the effects of CO depend on the activation of guanylate cyclase, which generates guanosine 3′,5′-monophosphate (cGMP), and the modulation of mitogen-activated protein kinase (MAPK) signaling pathways. This review highlights new advances in the interaction of CO with cellular signaling processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, MUH 628 NW, 3459 Fifth Avenue, Pittsburgh, PA 15213, USA.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Ryter, S. W., Morse, D., & Choi, A. M. (2004). Carbon Monoxide: To Boldly Go Where NO Has Gone Before. Science's STKE, 2004(230). https://doi.org/10.1126/stke.2302004re6
Vancouver
Ryter SW, Morse D, Choi AM. Carbon Monoxide: To Boldly Go Where NO Has Gone Before. Science's STKE. 2004;2004(230). doi:10.1126/stke.2302004re6
BibTeX
@article{Ryter2004,
author = {Ryter, Stefan W and Morse, Danielle and Choi, Augustine M K},
title = {Carbon Monoxide: To Boldly Go Where NO Has Gone Before},
journal = {Science's STKE},
year = {2004},
volume = {2004},
number = {230},
doi = {10.1126/stke.2302004re6}
}
EUVIMED